Login / Signup

The role of N-glycosylation modification in the pathogenesis of liver cancer.

Mengyu HuRui ZhangJiaren YangChenshu ZhaoWei LiuYuan HuangHao LyuShuai XiaoDong GuoCefan ZhouJingfeng Tang
Published in: Cell death & disease (2023)
N-glycosylation is one of the most common types of protein modifications and it plays a vital role in normal physiological processes. However, aberrant N-glycan modifications are closely associated with the pathogenesis of diverse diseases, including processes such as malignant transformation and tumor progression. It is known that the N-glycan conformation of the associated glycoproteins is altered during different stages of hepatocarcinogenesis. Characterizing the heterogeneity and biological functions of glycans in liver cancer patients will facilitate a deeper understanding of the molecular mechanisms of liver injury and hepatocarcinogenesis. In this article, we review the role of N-glycosylation in hepatocarcinogenesis, focusing on epithelial-mesenchymal transition, extracellular matrix changes, and tumor microenvironment formation. We highlight the role of N-glycosylation in the pathogenesis of liver cancer and its potential applications in the treatment or diagnosis of liver cancer.
Keyphrases
  • liver injury
  • extracellular matrix
  • drug induced
  • epithelial mesenchymal transition
  • cell surface
  • poor prognosis
  • transforming growth factor
  • signaling pathway
  • binding protein
  • amino acid